← Scroll for more →
Odyssey Therapeutics, Inc. (ODTX)
Biological Products, (No Diagnostic Substances)
Latest Price
$19.54
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
8.77
P/B Ratio
2.23
Institutional Ownership
71.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 5.18M | $96.0M | 10.81% | -- | 2026-06-30 |
| SR One Capital Management, LP | 3.79M | $71.0M | 7.92% | -- | 2026-06-30 |
| Tpg GP A, LLC | 3.69M | $69.0M | 7.71% | -- | 2026-06-30 |
| Lightspeed Management Company, L.L.C. | 3.61M | $67.0M | 7.53% | -- | 2026-06-30 |
| Orbimed Advisors LLC | 3.00M | $56.0M | 6.27% | -- | 2026-06-30 |
| Sanofi | 1.99M | $37.0M | 4.16% | -- | 2026-06-30 |
| Deerfield Management Company, L.P. | 1.05M | $19.0M | 2.18% | -- | 2026-06-30 |
| Sands Capital Alternatives, LLC | 875.0K | $16.0M | 1.83% | -- | 2026-06-30 |
| Hhlr Advisors, Ltd. | 831.7K | $15.0M | 1.74% | -- | 2026-06-30 |
| General Catalyst Group Management, LLC | 810.3K | $15.0M | 1.69% | -- | 2026-06-30 |